BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25778311)

  • 1. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results.
    Carvajal C; Navarro-Martin A; Cacicedo J; Ramos R; Guedea F
    J BUON; 2015; 20(1):158-65. PubMed ID: 25778311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiotherapy for oligometastatic lung tumors.
    Norihisa Y; Nagata Y; Takayama K; Matsuo Y; Sakamoto T; Sakamoto M; Mizowaki T; Yano S; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):398-403. PubMed ID: 18374506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
    Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
    Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative radiation therapy as first local therapy for lung oligometastases from colorectal cancer: a single-institution cohort study.
    Filippi AR; Badellino S; Ceccarelli M; Guarneri A; Franco P; Monagheddu C; Spadi R; Ragona R; Racca P; Ricardi U
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):524-9. PubMed ID: 25542308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
    Widder J; Klinkenberg TJ; Ubbels JF; Wiegman EM; Groen HJ; Langendijk JA
    Radiother Oncol; 2013 Jun; 107(3):409-13. PubMed ID: 23773410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic Body Radiation Therapy (SBRT) for lung metastases.
    Okunieff P; Petersen AL; Philip A; Milano MT; Katz AW; Boros L; Schell MC
    Acta Oncol; 2006; 45(7):808-17. PubMed ID: 16982544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases.
    Bae SH; Kim MS; Cho CK; Kang JK; Kang HJ; Kim YH; Shin US; Moon SM; Lee DH
    J Surg Oncol; 2012 Aug; 106(2):138-43. PubMed ID: 22297789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
    Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
    Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of single dose stereotactic radiotherapy for lung metastases.
    Osti MF; Carnevale A; Valeriani M; De Sanctis V; Minniti G; Cortesi E; Martelli M; Maurizi Enrici R
    Clin Lung Cancer; 2013 Nov; 14(6):699-703. PubMed ID: 23886798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions.
    Takeda A; Sanuki N; Tsurugai Y; Oku Y; Aoki Y
    J Radiat Res; 2016 Jul; 57(4):400-5. PubMed ID: 26983981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study.
    He X; Zhang P; Li Z; Bi F; Xu F; Wang X; Shen Y; Li Q; Qiu M
    Medicine (Baltimore); 2018 Oct; 97(40):e12601. PubMed ID: 30290630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer.
    Pasqualetti F; Montrone S; Vivaldi C; Zani M; Fedele D; Fornaro L; Pasqualetti G; Salvatore L; Manfredi B; Laliscia C; Coraggio G; Gonnelli A; Loupakis F; Masi G; Sainato A; Monzani F; Falcone A; Paiar F
    Anticancer Res; 2017 Jan; 37(1):315-319. PubMed ID: 28011508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy.
    Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
    Acta Oncol; 2019 Jan; 58(1):74-80. PubMed ID: 30280633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases.
    Kalinauskaite GG; Tinhofer II; Kufeld MM; Kluge AA; Grün AA; Budach VV; Senger CC; Stromberger CC
    BMC Cancer; 2020 May; 20(1):404. PubMed ID: 32393261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.
    Helou J; Thibault I; Poon I; Chiang A; Jain S; Soliman H; Erler D; Yeung L; Cheung P
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):419-427. PubMed ID: 28463162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study.
    Mazzola R; Fersino S; Ferrera G; Targher G; Figlia V; Triggiani L; Pasinetti N; Lo Casto A; Ruggieri R; Magrini SM; Alongi F
    Med Oncol; 2018 Aug; 35(9):121. PubMed ID: 30076479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.
    Qiu H; Katz AW; Chowdhry AK; Usuki KY; Singh DP; Metcalfe S; Cheruvu P; Chen Y; Okunieff P; Milano MT
    Am J Clin Oncol; 2018 Jan; 41(1):53-58. PubMed ID: 26270442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease.
    Osti MF; Agolli L; Valeriani M; Reverberi C; Bracci S; Marinelli L; De Sanctis V; Cortesi E; Martelli M; De Dominicis C; Minniti G; Nicosia L
    Lung Cancer; 2018 Aug; 122():165-170. PubMed ID: 30032826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.